221352-74-5 Usage
Description
(2S, 4S)-BOC-4-AMINO-1-FMOC-PYRROLIDINE-2-CARBOXYLIC ACID is a white powder chemical compound that serves as a key building block in the synthesis of various bioactive peptides and peptidomimetics. Its unique structure, featuring a protected amino group and a carboxylic acid functionality, allows for versatile applications in medicinal chemistry and drug development.
Uses
Used in Pharmaceutical Industry:
(2S, 4S)-BOC-4-AMINO-1-FMOC-PYRROLIDINE-2-CARBOXYLIC ACID is used as a synthetic intermediate for the preparation of low molecular weight cyclic peptides. These peptides act as inhibitors of SDF-1 binding to CXCR4, a chemokine receptor involved in various physiological processes, including immune response, cell trafficking, and cancer progression.
Used in Neuropharmacology Research:
In the field of neuropharmacology, (2S, 4S)-BOC-4-AMINO-1-FMOC-PYRROLIDINE-2-CARBOXYLIC ACID is utilized to design α-conotoxin analogs. These analogs specifically target α7 nicotinic acetylcholine receptors, which play a crucial role in cognitive function and are implicated in neurodegenerative diseases such as Alzheimer's disease. The development of such analogs can lead to potential therapeutic agents for the treatment of cognitive disorders.
Overall, (2S, 4S)-BOC-4-AMINO-1-FMOC-PYRROLIDINE-2-CARBOXYLIC ACID is a valuable compound in the realm of medicinal chemistry, with applications spanning from the development of therapeutic peptides to the creation of novel drug delivery systems and the design of targeted neuroactive agents.
Check Digit Verification of cas no
The CAS Registry Mumber 221352-74-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,2,1,3,5 and 2 respectively; the second part has 2 digits, 7 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 221352-74:
(8*2)+(7*2)+(6*1)+(5*3)+(4*5)+(3*2)+(2*7)+(1*4)=95
95 % 10 = 5
So 221352-74-5 is a valid CAS Registry Number.
221352-74-5Relevant articles and documents
Novel μ opioid antagonists derived from the μ opioid agonists endomorphin and [Dmt1]DALDA (H-Dmt-D-Arg-Phe-Lys-NH2)
Shi, Saijian,Xu, Jian,Feng, LingLing,Fan, Xin,Chen, Zhen,Qin, Yajuan,Chung, Nga N.,Li, Tingyou,Schiller, Peter W.
, p. 1305 - 1314 (2020/08/05)
Hybrid analogues of the μ opioid agonists endomorphin and [Dmt1]DALDA (H-Dmt-D-Arg-Phe-Lys-NH2, Dmt?=?2′,6′-dimethyltyrosine) containing cis-4-amino-Pro, trans-4-amino-Pro, cis-4-aminoethyl-Pro or cis-4-guanidinylethyl-Pro in the 2 p
Two prolines with a difference: contrasting stereoelectronic effects of 4R/S-aminoproline on triplex stability in collagen peptides [pro(X)-pro(Y)-Gly]n.
Umashankara,Babu, I Ramesh,Ganesh, Krishna N
, p. 2606 - 2607 (2007/10/03)
4R/S-Aminoprolines when present in the X-position of collagen peptide [pro(X)-pro(Y)-Gly]n exhibit pH- and stereochemistry-dependent effects on triplex stability.